Gosset Ownership
Private
Employees
~10
Therapeutic Areas
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Auritec Pharmaceuticals General Information
Auritec Pharmaceuticals has demonstrated sustained-release drug delivery profiles for a broad range of molecules in vitro, animal, and human trials, with at least one HIV program (a combination implant) pending for further clinical development.
Contact Information
Drug Pipeline
No pipeline data available
Key Partnerships
Oak Crest Institute of Science (historic, terminated)
Auritec Pharmaceuticals Funding
No funding data available
To view Auritec Pharmaceuticals's complete valuation and funding history, request access »